Australia News Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Australia News Reporter.

Press releases published on October 5, 2026

Oct. 5, 2026

DoDonPachi Resurrection Reignite: Training Mode Update & 10% OFF Steam Autumn Sale Out Now

Indeterminate EIN Presswire

Oct. 5, 2026

iatroX Updates Medical and Dental Exam Prep With Personalised Study Plans

Indeterminate EIN Presswire

Oct. 5, 2026

Lodestar Minerals Ltd (LSR.AX) Investor Webinar - Update on US Rare Earths and Ned's Creek

Indeterminate ABN Newswire

Oct. 5, 2026

Stelar Metals Limited (SLB.AX) Maiden Drilling Imminent at Hill of Leaders Project

Indeterminate ABN Newswire

Oct. 5, 2026

Free Tool RouterMap Shows UK Homes the Best Place to Put a Wi-Fi Router

Indeterminate EIN Presswire

Oct. 5, 2026

Mover Marketing AI Named Best Mover Marketing Company of 2026

Indeterminate EIN Presswire

Oct. 5, 2026

Small Talk Has a National Accent: Study Reveals How Brits, Canadians, Aussies, and Americans Really Make Conversation

Indeterminate EIN Presswire

Oct. 5, 2026

Best Office and Commercial Cleaning Companies in Perth 2026

Indeterminate EIN Presswire

Oct. 5, 2026

EZVIZ Australia: Expanding a Next-Generation Smart Home Security Ecosystem

Indeterminate EIN Presswire

Oct. 5, 2026

HtAG Analytics Launches Free Map of 8,000+ Australian Infrastructure Projects for Buyer's Agents and Investors

Indeterminate EIN Presswire

Oct. 5, 2026

CTI Answers - Now Inside Microsoft Teams

Indeterminate EIN Presswire

Oct. 5, 2026

Outstanding Pest Control Company Officially Launches Across Melbourne's South-East, East, North and Inner City

Indeterminate GlobeNewswire

Oct. 5, 2026

Medela Recognised by Australian Mums with Three MumPower Approved™ Seals

Indeterminate EIN Presswire

Oct. 5, 2026

Radiopharm Completes Productive End-of-Phase 2 Meeting with U.S. Food and Drug Administration for Pivotal Development Program of RAD101

Indeterminate GlobeNewswire

Oct. 5, 2026

Alterity Therapeutics Presents New Analyses of ATH434 Phase 2 Data in Multiple System Atrophy at the 2026 International Congress of Parkinson’s Disease and Movement Disorders

Indeterminate GlobeNewswire

Oct. 5, 2026

Aravax to Communicate Results of its Phase 2 Clinical Trial of PVX108, a Novel immunotherapy for the Treatment of Peanut Allergy, at Major Scientific Meetings in November 2026

Indeterminate GlobeNewswire